NICE in the dock as Servier takes osteoporosis review to court
The UK’s drugs watchdog is being dragged into a legal battle over its osteoporosis ruling, which has been labelled as “unethical and short-sighted” by critics.
Read MoreAuthor: Katrina Megget
Seroquel increases diabetes by almost 400% claims doctor
Patients taking AstraZeneca’s antipsychotic Seroquel have an almost 400% increased risk of developing diabetes, an endocrinologist has told a US court.
Read MoreReNeuron clinical trials with stem cells get the green light
UK-based stem cell company ReNeuron has been given the thumbs up by UK regulators to start clinical trials using stem cell therapy.
Read MoreCombined hypertension drugs increase risk of kidney disease and death
Patients treated with a combination of two types of hypertension drugs have an increased risk of cardiac death, kidney disease and likelihood of dialysis, the Heart and Stroke Foundation of Canada warns.
Read MoreBiotech asks US Government for help
The Biotechnology Industry Organisation is asking the US Government for a financial stimulus for small biotech companies that are struggling during the credit crunch.
Read More- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
